Open access
Jul 2026
Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma.
RPLP0 is aberrantly upregulated in ccRCC, promoting tumor progression, migration, and invasion by facilitating the EMT process and highlighting its potential as a robust prognostic biomarker and a regulator of tumor-microenvironment interactions.
Bin Wang, Hong-Quan Liu, Yicheng Guo et al.
· BMC Cancer · 0 citations